510(k) device
Polaris Spinal Growth System
Zimmer Biomet Spine, Inc. · Growing Rod System (PGM, Class II) · First FDA decision Mar 15, 2018, newest Mar 15, 2018Scoliosis and spinal deformity
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
510(k) pathway
Device trials
11
Naming "Polaris"
MAUDE reports
1,369
Brand "Polaris", since 2015
PubMed studies
665
Mentioning "Polaris"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Polaris Spinal Growth System
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
K180227 · Decided Mar 15, 2018 · 48 days after receipt
Device type: Growing Rod System (PGM) · Orthopedic Surgery
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Polaris", any status and sponsor, newest update first.
- Different Laser Frequencies on Neuropathic Outcomes in Patients With Bell's PalsyPivotal-lookingCompleted
Kafrelsheikh UniversityAcademic, hospital or other
NCT07519421 · 104 participants · Start Dec 1, 2025 · Primary completion May 1, 2026
Device: sham laser therapy; Low-Level Laser Therapy and 2 more · For: Neuropathy, Facial; Bell Palsy; Laser
Sites: Madinah, Saudi Arabia
The Hospital for Sick ChildrenAcademic, hospital or other
NCT07742358 · 20 participants (planned) · Start Sep 1, 2026 · Primary completion Sep 1, 2027
Device: Polaris Ultra Ureteral Stent; Cook Double-J Ureteral Stent · For: Pediatric Urolithiasis; Ureteral Stent-Related Symptoms
Sites: Toronto, Canada
- Polymer-free Sirolimus Eluting Stent: Real-world Investigation of Safety and OutcomesNot yet recruiting
Dorian GarinAcademic, hospital or other
NCT07563231 · 300 participants (planned) · Start Jun 2026 · Primary completion Jun 2028
Device: Polymer-free sirolimus-based submicron carrier-eluting stent Focus np (Abluminus np, Concept Medical, Tampa, FL, USA) · For: Coronary Artery Disease; Acute Coronary Syndrome; Myocardial Infarction and 2 more
Sites: Geneva, Switzerland
8 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Polaris", and for the whole product code for context.
This brand
1,369 reports: 1,059 malfunction, 307 injury, 3 death
Whole product code PGM
40 reports: 18 malfunction, 21 injury, 1 death
Newest reports for this brand
- Polaris UltraMalfunction
2124215-2026-57032 · Received Oct 27, 2026 · Event dated Sep 29, 2026
Device type: Stent, Ureteral (FAD)
Device problem as coded: Difficult or Delayed Positioning; Deformation Due to Compressive Stress
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
- Polaris UltraMalfunction
2124215-2026-56314 · Received Oct 23, 2026 · Event dated Jul 24, 2026
Device type: Stent, Ureteral (FAD)
Device problem as coded: Difficult to Advance
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
- Polaris 600Malfunction
9611500-2026-00539 · Received Oct 22, 2026 · Event dated Oct 9, 2026
Device type: Lamp, Surgical (FTD)
Device problem as coded: Disconnection; Device Fell
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Polaris"[tiab]. The summary above synthesizes these.
- Patient-reported outcomes: a Polaris for POLARIX.
Odejide OO, Abel GA · Blood · 2026Editorial, Comment
- The Space Omics and Medical Atlas (SOMA) and international astronaut biobank.
Overbey EG, Kim J, Tierney BT, et al. · Nature · 2024Research Support, N.I.H., Extramural
- POLARIS and Emerging Translational Efforts to Interrogate the Genomic Landscape of CDK4/6 Inhibitor Resistance.
Michaels E, Wander SA · JCO Precis Oncol · 2025Editorial
- POLARIS: Polygenic LD-adjusted risk score approach for set-based analysis of GWAS data.
Baker E, Schmidt KM, Sims R, et al. · Genet Epidemiol · 2018Research Support, Non-U.S. Gov't
- Polaris Observatory-supporting informed decision-making at the national, regional, and global levels to eliminate viral hepatitis.
Razavi H · Antivir Ther · 2022
- Q&A with Carolyn S.P. Lam.
Lam CSP · Med · 2026Interview, Historical Article
- POLARIS: Path of Least Action Analysis on Energy Landscapes.
Seitz E, Frank J · J Chem Inf Model · 2020Research Support, N.I.H., Extramural
- Efficacy, Safety, and Correlative Biomarkers of Toripalimab in Previously Treated Recurrent or Metastatic Nasopharyngeal Carcinoma: A Phase II Clinical Trial (POLARIS-02).
Wang FH, Wei XL, Feng J, et al. · J Clin Oncol · 2021Clinical Trial, Phase II, Multicenter Study
- POLArIS, a versatile probe for molecular orientation, revealed actin filaments associated with microtubule asters in early embryos.
Sugizaki A, Sato K, Chiba K, et al. · Proc Natl Acad Sci U S A · 2021Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
- Development of nanobody-based POLArIS orientation probes enabled multi-color/multi-target orientation imaging in living cells.
Nakai N, Sato K, Tani T, et al. · Biochem Biophys Res Commun · 2021Research Support, Non-U.S. Gov't
- Polaris Challenge: Data-Driven Priors to Improve Docking for Pose Prediction.
Sun K, Wang Y, Purnomo J, et al. · J Chem Inf Model · 2025
- POLARIS: a prospective, multicenter, noninterventional study assessing palbociclib in hormone receptor-positive advanced breast cancer.
Tripathy D, Blum JL, Rocque GB, et al. · Future Oncol · 2020Multicenter Study, Observational Study
Other devices of this type
Also filed under product code PGM.
- SDS Growing RodBAAT Medical Products B.V. · 510(k) 2026
- VerteGlide Spinal Growth Guidance SystemOrthoPediatrics Corp. · 510(k) 2025
- MARVEL Growing RodsGlobus Medical, Inc. · 510(k) 2022
- Daytona® Small Stature Growth Rod Conversion SetSeaSpine Orthopedics Corporation · 510(k) 2020
- CrossOver Cross ConnectorsMedos International SARL · 510(k) 2019
- CREO® Stabilization System, REVERE® Stabilization SystemGlobus Medical, Inc. · 510(k) 2018
- NuVasive® Growth Rod Conversion SetNu Vasive, Incorporated · 510(k) 2017
- K2M Growing Spine SystemK2m, Inc. · 510(k) 2016
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.